Real-time enrollment status for this congenital muscular dystrophy with itga7 (integrin alpha-7) deficiency clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:48 PM UTC
| NCT Number | NCT01403402 |
| Recruiting Status | Recruiting |
| Condition | Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 4,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Cure CMD |
| Last Updated on CT.gov | August 9, 2021 (Aug 9, 2021) |
As of July 17, 2026: Clinical trial NCT01403402 is currently recruiting participants. This clinical trial study for congenital muscular dystrophy with itga7 (integrin alpha-7) deficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by Cure CMD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01403402 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01403402 was last updated Aug 9, 2021 (August 9, 2021). HelloStudys verifies this status automatically.